Internal Server Error

Sanovas - About the company

Sanovas is a series A company based in San Rafael (United States), founded in 2009. It operates as a Platform of tools for interventional therapeutics and diagnostic applications in various specialties. Sanovas has raised $9.52M in funding. The company has 16 active competitors, including 4 funded and 6 that have exited. Its top competitors include companies like Pulmonx, Selio Medical and Novate Medical.

Company Details

Sanovas is a medical device company developing a platform of interventional surgical tools for use in various specialties. The company has received FDA 510(k) clearance to market its PulmoVia working channel. PulmoVia is disposable device a tool for diagnostic and therapeutic interventions in the lung. PulmoVia is used to introduce instruments to obtain tissue samples, retrieve foreign bodies, and initiate therapies within the lung while keeping their critical care patients breathing easily. The company is initially targeting the pulmonary market, which includes treatment of lung cancer, COPD, asthma and cystic fibrosis. Apart from this, Sanovas is also developing devices for interventional ENT, and interventional urology & gynaecology. Sanovas devices are being developed a few core platform tachnologies which include ViaTM Working Channels, VasZeppelinTM Smart Catheters, MicroCamTM Imaging Technologies, StablePathTM Catheter Anchoring Technology, PhysioSenseTM Physiologic Measurement Systems, CytoVasTM Tissue Collection Technology, and NanoVasTM Local Therapy Delivery Systems. As of August 2016, all Sanovas products are investigational medical devices except PulmoVia have not been FDA approved or cleared for use in the United States. Pulmo via is FDA 510(k) cleared.
Social
X
Key Metrics
Founded Year
2009
Location
San Rafael, United States
Stage
Series A
Total Funding
$9.52M in 3 rounds
Latest Funding Round
Ranked
Employee Count
13 as on Sep 30, 2026
Similar Companies
Sign up to download Sanovas' company profile

Sanovas's funding and investors

Sanovas has raised a total funding of $9.52M over 3 rounds. Its first funding round was on Jul 21, 2011.

Here is the list of recent funding rounds of Sanovas:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 04, 2015
4054965
Series A
9554212
2726526
7681001
9175767
Sep 18, 2013
9310491
Series A
7907168
9760735
4868084
5336288
Jul 21, 2011
4732381
Seed
6831403
3339368
8277604
2733009
lockAccess funding benchmarks and valuations. Sign up today!

Sanovas' founders and board of directors

Founder? Claim Profile

Sanovas' Board of Directors

Sanovas's board has 7 active members. Lawrence J. Gerrans, Ken Koen, Erhan Gundy, Bruce A. Nichols, Erhan Gunday, Larry Gerrans and Rob Georges are independent board members.
Here is the list of Sanovas' board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
16y 3m
kgjyilb
Independent board member
-
Current
8y 9m
hpinalu
Independent board member
-
Current
3y 7m
unmoczj
Independent board member
-
Current
5y 7m
ltjaygy
Independent board member
-
Current
4y 9m
hkzcqps
Independent board member
-
Current
2y 7m
joncf{a
Independent board member
-
Current
2y 7m

Sanovas' employee count trend

Sanovas has 13 employees as of Sep 26. Here is Sanovas's employee count trend over the years:
Employee count trend for Sanovas
lockUncover Sanovas' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Sanovas's Competitors and alternates

Top competitors of Sanovas include Pulmonx, Selio Medical and Novate Medical. Here is the list of Top 10 competitors of Sanovas, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Pulmonx
Pulmonx
1998, Redwood City (United States), Public
Developer of smart devices for treating pulmonary diseases
$281M
67/100
2nd
Logo for Selio Medical
Selio Medical
2016, Dublin (Ireland), Series A
Developer of device to prevent pneumothorax during transthoracic needle biopsy
$5.81M
52/100
3rd
Logo for Novate Medical
Novate Medical
2006, Galway (Ireland), Acquired
Provider of inferior vena cava filter for treatment of pulmonary embolism
$18M
46/100
4th
Logo for Spiration
Spiration
1999, Redmond (United States), Acqui-Hired
Emphysema treatment using minimally invasive Spiration Valve System to improve life
$73.9M
40/100
5th
Logo for Uptake Medical
Uptake Medical
2005, Tustin (United States), Acquired
Medical device company improving lives through vapor ablation for pulmonary disease
$71.7M
38/100
6th
Logo for Medos AG
Medos AG
1978, Stolberg (Germany), Acquired
Range of product and therapy solutions for cardiac surgeons and perfusionists.
-
-
37/100
7th
Logo for PneumRx
PneumRx
2004, Mountain View (United States), Acquired
Medical solutions innovator dedicated to transforming lives through science
$49.6M
33/100
8th
Logo for Sanovas
Sanovas
2009, San Rafael (United States), Series A
Platform of tools for interventional therapeutics and diagnostic applications in various specialties
$9.52M
-
32/100
9th
Logo for Emphasys Medical
Emphasys Medical
2000, Redwood City (United States), Acqui-Hired
Developer of endobronchial valves for the treatment of emphysema
$68.4M
32/100
10th
Logo for Axess Vision Technology
Axess Vision Technology
2006, Corps (France), Acqui-Hired
Products for video-Bronchoscopy, video-Ureteroscopy and video-Cystoscopy
$4.82M
32/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Sanovas's competitors? Click here to see the top ones

Sanovas's Investments and acquisitions

Sanovas has made no investments or acquisitions yet.

Reports related to Sanovas

Here is the latest report on Sanovas's sector:

News related to Sanovas

•
Sanovas Inc Product Pipeline Analysis, 2017 Update Prices from USD $750Sectorpublishingintelligence•May 08, 2017•Sanovas
•
Sanovas Expands Management TeamPR Newswire•Apr 28, 2014•Sanovas
•
Sanovas Awarded Patent for Extravasated Drug DeliveryPR Newswire•Oct 29, 2013•Sanovas
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Sanovas

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford